LGND - Ligand Pharmaceuticals Is A Lower Risk Biotech With A Cash Generative And Diversified Business Model
Business Overview
Ligand Pharmaceuticals (LGND) is a biopharmaceutical company concentrating on platforms and technologies that help pharmaceutical companies develop medicines. Ligand tends to focus on discovery and early-stage drug development while effectively outsourcing the late-stage development, regulatory management, and commercialization/marketing to its pharmaceutical partners. Ligand offers its shareholders economic access to a large portfolio of fully-funded programs, which it calls "Shots-on-Goal" through licensing its technology (e.g. platform technologies like Captisol or OmniAb). This creates a low cost/cash generative, diversified, and lower-risk business proposition when compared with many other firms who operate in the